| 2023 | 2022 | 2021 | ||||
|---|---|---|---|---|---|---|
| Revenue | 8,3 M € | — | — | |||
| EBITDA | -9,3 M € | -15.7% | -8,0 M € | -47.5% | -5,4 M € | |
| Operating profit | -14,4 M € | -26.1% | -11,5 M € | -47.6% | -7,8 M € | |
| Profit/loss | -14,2 M € | -22.9% | -11,6 M € | -50.6% | -7,7 M € | |
| Equity | -1,2 M € | -112.1% | 9,7 M € | +13.1% | 8,6 M € | |
| Total assets | 57,3 M € | +67.7% | 34,2 M € | +11.5% | 30,6 M € | |
| Cash | 11,1 M € | +55.0% | 7,1 M € | +32.7% | 5,4 M € | |
| Debts | 12,1 M € | +52.7% | 7,9 M € | -5.7% | 8,4 M € | |
| Staff | 69,1 | 49,4 | 40,1 | |||
Public limited company · Nivelles · incorporated on 02/03/2020 · 69,1 ETP
Company — Opening of bankruptcy.
Public limited company loss-making in the latest fiscal year. Cash position rising (+55.0%).
Solid counterparty for a standard engagement.
Quantoom Biosciences is a Public limited company incorporated in 2020. Its main activity is: Manufacture of pharmaceutical preparations. Its registered office is in Nivelles. It employs on average 69,1 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette